Lemtrada

Ended Awarded

Contract number
36C24121F0272
Awardee
Awarding agency
Obligated
$50,143

Award facts

Contract value 100% obligated
$50,142.96 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Cambridge, MA 02142, USA

Award details come from SAM.gov/FPDS.

About this award

Genzyme Corporation, operating through its Sanofi Genzyme division and Genzyme Therapeutics business unit, has been awarded a $50,142.96 firm fixed price delivery order against the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB) to provide LEMTRADA for the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1. Performance will take place in Cambridge, Massachusetts through September 30, 2021. No set-aside designation was used for this award issued by VHA, the healthcare system serving over nine million enrolled Veterans each year.

Quick answers

Who was awarded contract 36C24121F0272?

36C24121F0272 was awarded to Genzyme Corporation by Veterans Integrated Service Network 1 (Veterans Health Administration) on August 25, 2021.

How much is contract 36C24121F0272 worth?

The government has obligated $50,143 on 36C24121F0272.

Is contract 36C24121F0272 an order under another contract?

Yes. 36C24121F0272 is a delivery order under 36F79719D0153, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C24121F0272 competed?

The extent of competition for 36C24121F0272 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award